SynthesisClinical rheumatology2025

A systematic review and network meta-analysis comparing the efficacy and safety of deucravacitinib versus selected treatments for moderate to severe plaque psoriasis.

Jiaqi Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.